单点与多点扫描模式激光治疗糖尿病视网膜病变疗效比较

doi:10.3760/cma.j.cn115909-20201025-00413

Abstract
Figure/Table
References (23)
Related Citation (15)

Download: PDF (729 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Guide

Abstract Objective: To analyze and compare the effect of single-point and multi-point scanning mode for panretinal photocoagulation (PRP) on retinal structure and function in patients with non-proliferative diabetic retinopathy (NPDR). Methods: In a retrospective case series study, 57 patients (93 eyes) who were clinically diagnosed as severe NPDR and treated with PRP in Qingdao Municipal Hospital from January 2019 to July 2020 were analyzed retrospectively. Among them, PRP was performed on 27 patients (46 eyes) in single point scanning mode for 3-4 times as a control group. Thirty patients (47 eyes) underwent 532 nm multi-point scanning mode as an observation group, and PRP was performed twice. The therapeutic efficiency rate was calculated based on best corrected visual acuity. Pain was scored according to the numerical rating scale (NRS) on the day after laser treatment. The laser energy, the number of laser spots and the energy density were compared between the two groups. To observe the therapeutic effects, the mean sensitivity in the 30°-60° visual field, a/b-wave amplitude of F-ERG, and the central macular thickness (CMT) were compared between the two groups at 1 day, 1 month, 3 months, and 6 months after treatment. The non-perfusion area (NPA) was measured at 1 day preoperatively and neovascularization based on fundus fluorescein angiography (FFA) was observed at 6 months after treatment. Data were analyzed by a chi-square test, independent-samples t test and repeated measurements analysis of variance. Results: The effective rates of the control group and the observation group were 80% and 85%. The difference was not statistically significant (χ2 =0.36, P=0.55). The postoperative pain score of the observation group was significantly lower than that of control group (t=6.84, P<0.001). There were significant differences in laser energy and energy density between the two groups (t=0.24, P=0.02; t=12.84, P<0.001), but there was no significant difference in the number of laser spots between the two groups. One month and 3 months after treatment, the mean sensitivity in the 30°-60° visual field, a-wave amplitude of F-ERG and the central macular thickness range of the control group and the observation group were significantly different from parameters 1 day before treatment (P<0.001). The amplitudes of the F-ERG b waves at 1 month, 3 months and 6 months after treatment were significantly lower than those before treatment (P<0.001). There was no significant difference in NPA 1 day preoperatively. FFA at postoperative 6 months showed no neovascularization or obvious non-perfusion areas in either group. Conclusions: There is no difference in retinal structure and function in patients with severe NPDR treated with 532 nm single-point laser and multi-point scanning mode at 6 months postoperatively. However, the multi-point scanning mode can improve the compliance of patients with a shorter treatment time and less pain.

Key words： diabetic retinopathy panretinal photocoagulation single-point scanning laser multi-point scanning laser

Received: 25 October 2020

PACS:

Fund:

Corresponding Authors: Yu Zhang, Department of Ophthalmology, Qingdao Municipal Hospital Affiliated to Qingdao University, Qingdao 266000, China (Email: 93zhangyu@sina.com)

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

https://www.cjoovs.com/EN/ 10.3760/cma.j.cn115909-20201025-00413 OR https://www.cjoovs.com/EN/Y2021/V23/I5/356

[1]	张茉莉, 田蓓, 魏文斌. 577、532 nm激光全视网膜激光光凝治疗非增生型糖尿病视网膜病变疗效比较. 中华眼底病杂志, 2016, 32(2): 135-139. DOI: 10.3760/cma.j.issn.1005-1015. 2016.02.006.
[2]	Brader HS, Young LH. Subthreshold diode micropulse laser: A review. Semin Ophthalmol, 2016, 31(1-2): 30-39. DOI: 10.3109/08820538.2015.1114837.
[3]	中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年). 中华眼科杂志, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.
[4]	Rasta SH, Nikfarjam S, Javadzadeh A. Detection of retinal capillary nonperfusion in fundus fluorescein angiogram of diabetic retinopathy. Bioimpacts, 2015, 5(4): 183-190. DOI: 10.15171/bi.2015.27.
[5]	Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology, 1991, 98(5 Suppl): 807-822.
[6]	Mahgoub MM, Macky TA. The Effect of laser panretinal photocoagulation on diabetic macular edema using the Pascal® photocoagulator versus the conventional argon laser photocoagulator. Ophthalmologica, 2016, 235(3): 137-140. DOI: 10.1159/000444594.
[7]	Royle P, Mistry H, Auguste P, et al. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for nonproliferative diabetic retinopathy: Systematic review and economic evaluation. Health Technol Assess, 2015, 19(51): 1-247. DOI: 10.3310/hta19510.
[8]	许艳, 姚晶磊, 陈冬梅, 等. 改良与传统全视网膜光凝术治疗糖尿病视网膜病变疗效观察. 眼科新进展, 2017, 37(12): 1178-1181. DOI: 10.13389/j.cnki.rao.2017.0297.
[9]	范围, 邹欢, 袁容娣. 糖尿病黄斑水肿治疗研究现状与进展. 中华眼底病杂志, 2015, 31(2): 198-201. DOI: 10.3760/cma. j.issn.1005-1015.2015.02.027.
[10]	徐志伟, 伍海建, 金玲艳, 等. 单次玻璃体腔注射雷珠单抗联合激光治疗视网膜分支静脉阻塞继发黄斑水肿. 中华眼视光学与视觉科学杂志, 2018, 20(3): 168-173. DOI: 10.3760/cma. j.issn.1674-845X.2018.03.008.
[11]	Bressler NM, Beck RW, Ferris FL 3rd. Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med, 2011, 365(16): 1520-1526. DOI: 10.1056/NEJMct0908432.
[12]	Něm?anský J, Stepanov A, Něm?anská S, et al. Results of treatment of diabetic retinopathy by the laser system PASCAL. Cesk Slov Oftalmol, 2018, 73(5-6): 198-203.
[13]	Ye H, Yu M, Lu L, et al. Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation. Lasers Med Sci , 2018, 33(5): 1095-1102. DOI: 10.1007/s10103-018-2474-0.
[14]	Yilmaz I, Perente I, Saracoglu B, et al. Changes in pupil size following panretinal retinal photocoagulation: Conventional laser vs pattern scan laser (PASCAL). Eye (Lond), 2016, 30(10): 1359-1364. DOI: 10.1038/eye.2016.135.
[15]	谢田华, 包欣, 孙超, 等. 多点扫描激光与单点激光治疗糖尿病视网膜病变的对比研究. 眼科, 2019, 28(5): 345-349. DOI: 10.13281/j.cnki.issn.1004-4469.2019.05.006.
[16]	Amoaku WM, Ghanchi F, Bailey C, et al. Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group. Eye (Lond), 2020, 34(Suppl 1): 1-51. DOI: 10.1038/s41433-020-0961-6.
[17]	Calderon GD, Juarez OH, Hernandez GE, et al. Oxidative stress and diabetic retinopathy: Development and treatment. Eye (Lond), 2017, 31(8): 1122-1130. DOI: 10.1038/eye.2017.64.
[18]	唐孟苏, 张淑琦, 张帆. 多点扫描矩阵激光对重度非增殖性糖尿病性视网膜病变的疗效观察. 中国激光医学杂志, 2016, 25(4):190-195. DOI: 10.13480/j.issn1003-9430.2016.0190.
[19]	Park N, Lee IG, Kim JT. Changes in choroidal thickness in advanced diabetic retinopathy treated with pan-retinal photocoagulation using a pattern scanning laser versus a conventional laser. BMC Ophthalmol, 2020, 20(1): 226. DOI: 10.1186/s12886-020-01501-1.
[20]	Nemcansky J, Stepanov A, Nemcanska S , et al. Single session of pattern scanning laser versus multiple sessions of conventional laser for panretinal photocoagulation in diabetic retinopathy: Efficacy, safety and painfulness. PLoS One, 2019, 14(7): e0219282. DOI: 10.1371/journal.pone.0219282.
[21]	张茉莉, 田蓓, 魏文斌. 577 nm激光多点与单点扫描模式全视网膜激光光凝治疗非增生型糖尿病视网膜病变疗效比较. 中华眼底病杂志, 2015, 31(1): 36-40. DOI: 10.3760/cma. j.issn. 1005-1015.2015.01.010.
[22]	Bandello F, Cicinelli MV. 19th EURETINA Congress Keynote Lecture: Diabetic Retinopathy Today. Ophthalmologica, 2020, 243(3): 163-171. DOI: 10.1159/000506312.
[23]	郭桂兰, 张学东. 糖尿病视网膜病变多点扫描激光治疗的研究现状. 国际眼科杂志, 2013, 13(3): 493-495. DOI: 10.3980/ j.issn.1672-5123.2013.03.19.

[1]	. [J]. Chinese Journal of Optometry Ophthalmology and Visual science, 2023, 25(8): 0-.